Delivery Order SPE2DR25D2206-SPE2DR26F9CE1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,502.05 to AmerisourceBergen Drug Corp for Pegasys 180 micrograms per 0.5 milliliter syringes. This competitively awarded, firm fixed-price delivery order was issued on November 5, 2025, with an ultimate completion date of November 6, 2025. The pharmaceutical product will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed-price delivery order, valued at $4,050.57, is scheduled for completion by November 19, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- This delivery order, valued at $6,855.38, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under a child contract structure, leveraging the...
- The Defense Logistics Agency awarded a $5,800.84 delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on October 31, 2025, with an ultimate completion date of November 3, 2025. This is a firm fixed-price contract with no set-aside designation, executed through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes with a ceiling value of $17,402.52. This firm fixed price delivery order, which carries an ultimate completion date of November 6, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,990.37 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/ml vials. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply transaction. The award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,752.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,752.22 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This is a firm fixed price contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,402.52 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed-price, competitively awarded delivery order is set to be completed by November 13, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical distributor supporting federal medical procurement...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on July 14, 2025, with performance completion by July 15, 2025. This non-set-aside, firm fixed price contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger vehicle supporting the federal medical supply chain. This...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9CE1Delivery Order
The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of November 19, 2025. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical supply vendor for military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support defense healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Pegasys, an injectable antiviral medication, exemplifies the company's role in fulfilling specialized pharmaceutical procurement needs for federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 11/18/25 |